+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End Use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990554
Description Jump to:
The global hepatitis E diagnostic tests market size was estimated at USD 54.75 million in 2023 and is projected to grow at a CAGR of 4.77% from 2024 to 2030. This growth is attributed to the rising incidences of hepatitis E, increased awareness about the need for early detection, and advancement in diagnostic technologies. According to the World Health Organization (WHO), approximately 20 million people worldwide are infected with the hepatitis E virus (HEV) each year, leading to approximately 3.3 million cases of symptomatic hepatitis E.

The global market has witnessed significant technological advancements in recent years, driving improvements in the accuracy, efficiency, and accessibility of diagnostic solutions. For Instance, in June 2021, DiaSorin introduced the fully automated high-throughput CLIA solution for diagnosis, available in countries that accept the CE market. DiaSorin's new offering represents a significant advancement in hepatitis E diagnostics. The fully automated CLIA (Chemiluminescence Immunoassay) platform enables high-throughput testing, allowing healthcare providers to screen and diagnose many patients efficiently. This is particularly important in regions with a high prevalence of hepatitis E, where the ability to identify infected individuals rapidly is crucial for effective disease management and prevention. The availability of such advanced diagnostic platforms aligns with the growing demand for accurate and efficient hepatitis E testing solutions.

Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also significant in driving market growth. Greater awareness about the risks and consequences of hepatitis E, such as the higher mortality rates in pregnant women, is fueling the demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List reflects the increasing global recognition of the importance of early detection and management of hepatitis E.

Governments and healthcare systems recognize the need for improved surveillance and outbreak management, leading to increased procurement of HEV diagnostic kits. Patients and clinicians also seek better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For instance, the Government of India comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including Hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. The program involves significant government funding and a decentralized implementation strategy to strengthen the healthcare system's capacity to manage viral hepatitis effectively.

The increasing healthcare expenditure, particularly in emerging markets, is supporting the market growth. The growing emphasis on early detection and effective disease management is driving the demand for diagnostic tests. As awareness about the disease increases, there is a greater focus on implementing preventive measures such as personal hygiene, safe water sources, proper sanitation, and food safety to curb the spread of the virus.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the publisher has segmented the global hepatitis E diagnostic tests market report based on type, end use, and region.
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • Polymerase Chain Reaction (PCR)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital
  • Diagnostics Laboratories
  • Blood Banks
  • Other End User
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidences of hepatitis E
3.2.1.2. Technological advancements
3.2.1.3. Efforts to raise awareness
3.2.2. Market restraint analysis
3.2.2.1. Lack of awareness and access to Hepatitis E testing in developing regions
3.3. Hepatitis E Diagnostic Tests Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
Chapter 4. Hepatitis E Diagnostic Tests Market: Treatment Estimates & Trend Analysis
4.1. Global Hepatitis E Diagnostic Tests Market: Type Dashboard
4.2. Global Hepatitis E Diagnostic Tests Market: Type Analysis
4.3. Global Hepatitis E Diagnostic Tests Market by Type, Revenue
4.4. ELISA HEV IgM Test
4.4.1. ELISA HEV IgM Test market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. ELISA HEV IgG Test
4.5.1. ELISA HEV IgG Test market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Rapid Diagnostics Test
4.6.1. Rapid Diagnostics Test market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Polymerase Chain Reaction (PCR)
4.7.1. Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Estimates & Trend Analysis
5.1. Global Hepatitis E Diagnostic Tests Market: End Use Dashboard
5.2. Global Hepatitis E Diagnostic Tests Market: End Use Movement Analysis
5.3. Global Hepatitis E Diagnostic Tests Market Estimates and Forecasts, By End Use, Revenue (USD Million)
5.4. Hospital
5.4.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Diagnostics Laboratories
5.5.1. Diagnostic Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Blood Banks
5.6.1. Blood Banks market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Other End Use
5.7.1. Other End Use market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis by Type and End Use
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Vendor Landscape
7.2.1. List of key distributors and channel partners
7.2.2. Key customers
7.2.3. Key company market share analysis, 2023
7.2.4. Wantai BioPharm
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. MP Biomedicals LLP
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. PerkinElmer, Inc
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. DIa.Pro diagnostic Bioprobes srl
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. ELITechGroup
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Primerdesign Ltd
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. F.Hoffmann-La Roche Ltd
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Mikrogen GmbH
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Altona Diagnostics
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Fortress Diagnostics
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
List of Tables
Table 1 List Of Abbreviation
Table 2 North America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
Table 3 North America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 4 North America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 5 U.S. Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 6 U.S. Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 7 Canada Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 8 Canada Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 9 Mexico Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 10 Mexico Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 11 Europe Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
Table 12 Europe Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 13 Europe Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 14 Germany Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 15 Germany Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 16 UK Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 17 UK Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 18 France Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 19 France Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 20 Italy Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 21 Italy Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 22 Spain Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 23 Spain Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 24 Denmark Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 25 Denmark Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 26 Sweden Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 27 Sweden Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 28 Norway Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 29 Norway Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
Table 31 Asia Pacific Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 33 China Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 34 China Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 35 Japan Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 36 Japan Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 37 India Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 38 India Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 39 South Korea Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 40 South Korea Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 41 Australia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 42 Australia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 43 Thailand Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 44 Thailand Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 45 Latin America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
Table 46 Latin America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 47 Latin America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 48 Brazil Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 49 Brazil Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 50 Argentina Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 51 Argentina Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 52 MEA Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
Table 53 MEA Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 54 MEA Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 55 South Africa Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 56 South Africa Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 59 UAE Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 60 UAE Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
Table 61 Kuwait Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
Table 62 Kuwait Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Hepatitis E diagnostic tests market outlook
Fig. 14 Hepatitis E diagnostic tests competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Hepatitis E diagnostic tests market driver impact
Fig. 18 Hepatitis E diagnostic tests market restraint impact
Fig. 19 Hepatitis E diagnostic tests market: Type movement analysis
Fig. 20 Hepatitis E diagnostic tests market: Type outlook and key takeaways
Fig. 21 ELISA HEV IgM test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 ELISA HEV IgG test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Rapid Diagnostics test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Hepatitis E diagnostic tests market: End Use movement analysis
Fig. 26 Hepatitis E diagnostic tests market: End Use outlook and key takeaways
Fig. 27 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Other End User market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Hepatitis E diagnostic tests market: Regional movement analysis
Fig. 32 Hepatitis E diagnostic tests market: Regional outlook and key takeaways
Fig. 33 Hepatitis E diagnostic tests market share and leading players
Fig. 34 North America, by country
Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 US key country dynamics
Fig. 37 US market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada key country dynamics
Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Mexico key country dynamics
Fig. 41 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 UK key country dynamics
Fig. 44 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Germany key country dynamics
Fig. 46 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 France key country dynamics
Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Italy key country dynamics
Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Spain key country dynamics
Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Denmark key country dynamics
Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Sweden key country dynamics
Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Norway key country dynamics
Fig. 58 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 China key country dynamics
Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Japan key country dynamics
Fig. 63 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 India key country dynamics
Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Thailand key country dynamics
Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 South Korea key country dynamics
Fig. 69 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Australia key country dynamics
Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Brazil key country dynamics
Fig. 74 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Argentina key country dynamics
Fig. 76 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 South Africa key country dynamics
Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Saudi Arabia key country dynamics
Fig. 81 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 UAE key country dynamics
Fig. 83 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Kuwait key country dynamics
Fig. 85 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Market share of key market players- Hepatitis E Diagnostic Tests market

Companies Mentioned

  • Altona Diagnostics
  • Dia.Pro Diagnostic Bioprobes srl
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • Mikrogen GmbH
  • MP Biomedicals LLP
  • PerkinElmer, Inc
  • Primerdesign Ltd
  • Wantai BioPharm

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 54.75 Million
Forecasted Market Value ( USD ) by 2030 $ 75.58 Million
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global STD Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments and Services, Consumables), Application (HIV Testing, HSV Testing, Chlamydia Testing), Technology, Location of Testing, Region, and Segment Forecasts, 2024-2030 - Product Image

Global STD Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments and Services, Consumables), Application (HIV Testing, HSV Testing, Chlamydia Testing), Technology, Location of Testing, Region, and Segment Forecasts, 2024-2030

  • Report
  • 156 Pages
  • Global
From
Global Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Forecast 2024-2030 - Product Image

Global Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Nucleic Acid Testing, Detection of Latent Infection), By End-use (Diagnostic Laboratories, Hospitals), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Nucleic Acid Testing, Detection of Latent Infection), By End-use (Diagnostic Laboratories, Hospitals), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 110 Pages
  • Global
From
Viral Hepatitis and Retrovirus Diagnostic Tests - Global Strategic Business Report - Product Image

Viral Hepatitis and Retrovirus Diagnostic Tests - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.